Hangzhou, China

Zhenxing Zhou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Doer Biologics Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhenxing Zhou. Retrieved from https://idiyas.com/inventor/zhenxing-zhou-lj5auug8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhenxing Zhou: Innovator in Biological Research

Introduction

Zhenxing Zhou is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biology, particularly in the development of innovative antibodies. His work focuses on advancing medical research and therapeutic applications.

Latest Patents

Zhenxing Zhou holds 1 patent for his invention titled "Heavy-chain antibodies (VHHs) against claudin 18A2 and use thereof." This patent relates to an anti-CLD18A2 VHH, which includes a complementarity determining region (CDR) with specific amino acid sequences. The anti-CLD18A2 VHH can specifically bind to the epitope on CLD18A2, demonstrating good specificity and affinity, along with a noticeable tumor suppression effect.

Career Highlights

Throughout his career, Zhenxing Zhou has worked with notable companies, including Zhejiang Doer Biologics Co., Ltd. and Zhejiang Doer Biologics Corporation. His experience in these organizations has contributed to his expertise in biological innovations.

Collaborations

Zhenxing Zhou has collaborated with esteemed colleagues such as Gaofeng Yao and Yali Lu. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Zhenxing Zhou's contributions to biological research and his innovative patents highlight his role as a key figure in advancing medical science. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…